W Randall Russell, MD
Surgery · Wynnewood, PANPI 1104823475
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Stryker at 31.9% of the total. Reporting peaked in 2019 at $1,005 and has fallen 80.2% since, to $199 in 2025.
Across 67 payments — averaging $39.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$848
- Smith+Nephew$618
- Cashflow Solutions, LLC$511
- Resmed Corp$95
- Organogenesis Inc.$82
- Convatec Inc.$71
- plus $433 from 12 others
What the payments were for
- Consulting fees$50019%
- Travel & lodging$84832%
- Food & beverage$1,30949%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 4 | $848 |
| Smith+Nephew | 32 | $618 |
| Cashflow Solutions, LLC | 2 | $511 |
| Resmed Corp | 3 | $95 |
| Organogenesis Inc. | 4 | $82 |
| Convatec Inc. | 3 | $71 |
| Solventum Corporation | 3 | $68 |
| KCI USA, Inc. | 3 | $63 |
| AbbVie | 2 | $53 |
| Tactile Systems Technology Inc | 3 | $51 |
| Hydrofera LLC | 1 | $38 |
| Next Science LLC | 1 | $26 |
| Medtronic | 1 | $26 |
| Hartmann USA, Inc. | 1 | $25 |
| Medline Industries LP | 1 | $22 |
| Shire North American Group Inc | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,657 in reported general payments places this provider in the 65th percentile of 1,424 surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 50 | $2,755 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 37 | $874 |
| Mupirocin | 50 | $386 |
| Silver Sulfadiazine | 16 | $369 |
| Lidocaine | 13 | $354 |
| Doxycycline Hyclate | 31 | $352 |
| Triamcinolone Acetonide | 46 | $265 |
| Gabapentin | 14 | $229 |
| Cephalexin | 13 | $91 |
Paid to pharmacies, not to this prescriber.
Other surgery in Wynnewood
- Andy KiserPittsburgh$1M
- Glenn SteeleDanville$698K
- Maher El ChaarAllentown$667K
- George EidPittsburgh$619K
- Paul CesanekAllentown$469K
- Clark GerhartPlains$317K
- Irina YermilovPlymouth Meeting$315K
- Eric PauliHershey$202K
- Ariel AballayPittsburgh$198K
- Ann RogersHershey$198K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.